세계의 인슐린 펜 : 시장 점유율과 순위, 전체적인 판매량과 수요 예측2025-2031년

The global market for Insulin Pen was estimated to be worth US$ 6013 million in 2024 and is forecast to a readjusted size of US$ 10519 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Insulin Pen cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

An insulin pen is a portable, dose-controlled medical device designed for subcutaneous insulin delivery in diabetes patients. Typically consisting of a pen body and a replaceable needle, it offers a user-friendly alternative to traditional vial-and-syringe methods. Insulin pens provide advantages such as accurate dosing, ease of use, portability, and enhanced patient adherence. They are available in both disposable and reusable forms and are commonly used with prefilled cartridges for Type 1 and Type 2 diabetes management. As an essential tool in chronic disease control, insulin pens are accelerating the standardization and personalization of insulin therapy worldwide.

With the global prevalence of diabetes rising steadily and chronic disease management gaining attention, insulin pens are experiencing rapid market growth as a key tool to improve treatment compliance and ease of administration. Leading pharmaceutical and medical device companies are actively investing in product innovation, including smart insulin pens and digitally integrated systems, to enhance real-time connectivity between patients and healthcare providers. Government policies supporting standardized diabetes care at the primary level are also expanding market penetration, particularly in underserved regions.

Despite technological advancements, several challenges remain in the insulin pen industry. In some regions, limited reimbursement coverage and high out-of-pocket costs still hinder widespread adoption. Price competition from low-cost generics is putting pressure on originator brands. Additionally, issues such as device compatibility and lack of standardized consumables may limit international scalability. Global expansion also requires navigating regulatory variations and building resilient supply chains to mitigate operational risks.

End-user demand is shifting from passive treatment to active disease management, especially among younger patients who prefer smart monitoring and remote support. Insulin pens are increasingly integrated into digital ecosystems alongside glucose meters and mobile apps, reinforcing the shift toward connected chronic care. Disposable pens, due to their convenience, are seeing rising adoption across hospitals and primary care settings. With global aging trends, demand will grow for insulin pens that offer safety, usability, and traceability, driving the next phase of market evolution.

This report aims to provide a comprehensive presentation of the global market for Insulin Pen, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Insulin Pen by region & country, by Type, and by Application.

The Insulin Pen market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Pen.

Market Segmentation

By Company

• Novo Nordisk
• Eli Lilly
• Sanofi
• Embecta
• MDT Group
• Dongbao
• Owen Mumford
• Ganlee

Segment by Type

• Reusable Insulin Pen
• Disposable Insulin Pen

Segment by Application

• Hospitals
• Clinics
• The Chemist's Shops

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Insulin Pen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Insulin Pen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Insulin Pen in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Insulin Pen Product Introduction
• 1.2 Global Insulin Pen Market Size Forecast
  • 1.2.1 Global Insulin Pen Sales Value (2020-2031)
  • 1.2.2 Global Insulin Pen Sales Volume (2020-2031)
  • 1.2.3 Global Insulin Pen Sales Price (2020-2031)
• 1.3 Insulin Pen Market Trends & Drivers
  • 1.3.1 Insulin Pen Industry Trends
  • 1.3.2 Insulin Pen Market Drivers & Opportunity
  • 1.3.3 Insulin Pen Market Challenges
  • 1.3.4 Insulin Pen Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Insulin Pen Players Revenue Ranking (2024)
• 2.2 Global Insulin Pen Revenue by Company (2020-2025)
• 2.3 Global Insulin Pen Players Sales Volume Ranking (2024)
• 2.4 Global Insulin Pen Sales Volume by Company Players (2020-2025)
• 2.5 Global Insulin Pen Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Insulin Pen Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Insulin Pen Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Insulin Pen
• 2.9 Insulin Pen Market Competitive Analysis
  • 2.9.1 Insulin Pen Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Insulin Pen Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Pen as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Reusable Insulin Pen
  • 3.1.2 Disposable Insulin Pen
• 3.2 Global Insulin Pen Sales Value by Type
  • 3.2.1 Global Insulin Pen Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Insulin Pen Sales Value, by Type (2020-2031)
  • 3.2.3 Global Insulin Pen Sales Value, by Type (%) (2020-2031)
• 3.3 Global Insulin Pen Sales Volume by Type
  • 3.3.1 Global Insulin Pen Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Insulin Pen Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Insulin Pen Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Insulin Pen Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Hospitals
  • 4.1.2 Clinics
  • 4.1.3 The Chemist's Shops
• 4.2 Global Insulin Pen Sales Value by Application
  • 4.2.1 Global Insulin Pen Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Insulin Pen Sales Value, by Application (2020-2031)
  • 4.2.3 Global Insulin Pen Sales Value, by Application (%) (2020-2031)
• 4.3 Global Insulin Pen Sales Volume by Application
  • 4.3.1 Global Insulin Pen Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Insulin Pen Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Insulin Pen Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Insulin Pen Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Insulin Pen Sales Value by Region
  • 5.1.1 Global Insulin Pen Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Insulin Pen Sales Value by Region (2020-2025)
  • 5.1.3 Global Insulin Pen Sales Value by Region (2026-2031)
  • 5.1.4 Global Insulin Pen Sales Value by Region (%), (2020-2031)
• 5.2 Global Insulin Pen Sales Volume by Region
  • 5.2.1 Global Insulin Pen Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Insulin Pen Sales Volume by Region (2020-2025)
  • 5.2.3 Global Insulin Pen Sales Volume by Region (2026-2031)
  • 5.2.4 Global Insulin Pen Sales Volume by Region (%), (2020-2031)
• 5.3 Global Insulin Pen Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Insulin Pen Sales Value, 2020-2031
  • 5.4.2 North America Insulin Pen Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Insulin Pen Sales Value, 2020-2031
  • 5.5.2 Europe Insulin Pen Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Insulin Pen Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Insulin Pen Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Insulin Pen Sales Value, 2020-2031
  • 5.7.2 South America Insulin Pen Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Insulin Pen Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Insulin Pen Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Insulin Pen Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Insulin Pen Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Insulin Pen Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Insulin Pen Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Insulin Pen Sales Value, 2020-2031
  • 6.3.2 United States Insulin Pen Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Insulin Pen Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Insulin Pen Sales Value, 2020-2031
  • 6.4.2 Europe Insulin Pen Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Insulin Pen Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Insulin Pen Sales Value, 2020-2031
  • 6.5.2 China Insulin Pen Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Insulin Pen Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Insulin Pen Sales Value, 2020-2031
  • 6.6.2 Japan Insulin Pen Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Insulin Pen Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Insulin Pen Sales Value, 2020-2031
  • 6.7.2 South Korea Insulin Pen Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Insulin Pen Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Insulin Pen Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Insulin Pen Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Insulin Pen Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Insulin Pen Sales Value, 2020-2031
  • 6.9.2 India Insulin Pen Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Insulin Pen Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Novo Nordisk
  • 7.1.1 Novo Nordisk Company Information
  • 7.1.2 Novo Nordisk Introduction and Business Overview
  • 7.1.3 Novo Nordisk Insulin Pen Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Novo Nordisk Insulin Pen Product Offerings
  • 7.1.5 Novo Nordisk Recent Development
• 7.2 Eli Lilly
  • 7.2.1 Eli Lilly Company Information
  • 7.2.2 Eli Lilly Introduction and Business Overview
  • 7.2.3 Eli Lilly Insulin Pen Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Eli Lilly Insulin Pen Product Offerings
  • 7.2.5 Eli Lilly Recent Development
• 7.3 Sanofi
  • 7.3.1 Sanofi Company Information
  • 7.3.2 Sanofi Introduction and Business Overview
  • 7.3.3 Sanofi Insulin Pen Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Sanofi Insulin Pen Product Offerings
  • 7.3.5 Sanofi Recent Development
• 7.4 Embecta
  • 7.4.1 Embecta Company Information
  • 7.4.2 Embecta Introduction and Business Overview
  • 7.4.3 Embecta Insulin Pen Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Embecta Insulin Pen Product Offerings
  • 7.4.5 Embecta Recent Development
• 7.5 MDT Group
  • 7.5.1 MDT Group Company Information
  • 7.5.2 MDT Group Introduction and Business Overview
  • 7.5.3 MDT Group Insulin Pen Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 MDT Group Insulin Pen Product Offerings
  • 7.5.5 MDT Group Recent Development
• 7.6 Dongbao
  • 7.6.1 Dongbao Company Information
  • 7.6.2 Dongbao Introduction and Business Overview
  • 7.6.3 Dongbao Insulin Pen Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Dongbao Insulin Pen Product Offerings
  • 7.6.5 Dongbao Recent Development
• 7.7 Owen Mumford
  • 7.7.1 Owen Mumford Company Information
  • 7.7.2 Owen Mumford Introduction and Business Overview
  • 7.7.3 Owen Mumford Insulin Pen Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Owen Mumford Insulin Pen Product Offerings
  • 7.7.5 Owen Mumford Recent Development
• 7.8 Ganlee
  • 7.8.1 Ganlee Company Information
  • 7.8.2 Ganlee Introduction and Business Overview
  • 7.8.3 Ganlee Insulin Pen Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Ganlee Insulin Pen Product Offerings
  • 7.8.5 Ganlee Recent Development

8 Industry Chain Analysis

• 8.1 Insulin Pen Industrial Chain
• 8.2 Insulin Pen Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Insulin Pen Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Insulin Pen Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer